|
Volumn 48, Issue 3, 1998, Pages 245-250
|
Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice
a
|
Author keywords
3 4 2 (5 Methyl 2 phenyl oxazol 4 yl)ethoxy phenyl 2S propylamino propionic acid; Antidiabetic agent; CAS 185679 16 7; Diabetes mellitus, experimental, non insulin dependent; HQL 975, effects on glucos and lipid metabolism
|
Indexed keywords
3 {4 [2 (5 METHYL 2 PHENYLOXAZOL 4 YL)ETHOXY]PHENYL}PROPYLAMINOPROPIONIC ACID;
ANTIDIABETIC AGENT;
CHOLESTEROL;
FATTY ACID SYNTHASE;
GLUCOSE;
INSULIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ADIPOSE TISSUE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
GLUCOSE TOLERANCE;
GLUCOSE UTILIZATION;
GLYCOGEN SYNTHESIS;
HYPOGLYCEMIA;
INSULIN BLOOD LEVEL;
LIPID METABOLISM;
LIPOGENESIS;
MALE;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
TRIACYLGLYCEROL BLOOD LEVEL;
ANIMALS;
BLOOD GLUCOSE;
BODY WEIGHT;
DIABETES MELLITUS, TYPE 2;
GLYCOGEN;
HYPOGLYCEMIC AGENTS;
INSULIN;
LACTIC ACID;
LIPIDS;
LIVER;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, INBRED ICR;
|
EID: 0031892274
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (18)
|